The minimal important difference in symptoms and rescue free days

S. Tomkins, L. Frith, L. Jacques, R. Stanford, P. Dale (Stevenage, London, United Kingdom; RTP, United States Of America)

Source: Annual Congress 2010 - Management of airway disease
Session: Management of airway disease
Session type: Thematic Poster Session
Number: 4557
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Tomkins, L. Frith, L. Jacques, R. Stanford, P. Dale (Stevenage, London, United Kingdom; RTP, United States Of America). The minimal important difference in symptoms and rescue free days. Eur Respir J 2010; 36: Suppl. 54, 4557

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How important is a minimal difference?
Source: Eur Respir J 2011; 37: 755-756
Year: 2011


Minimal important difference of change in patient-specific goals in severe emphysema patients
Source: ERJ Open Res, 6 (4) 00459-2020; 10.1183/23120541.00459-2020
Year: 2020



The minimal clinically important difference for COPD health status tools measured with global ratings of change during different time periods
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Minimal important difference for the asthma control questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 460s
Year: 2004

Significant percentage of asthma patients failed to achieve control in the first year after initiating medium or high dose ICS/LABA
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017


COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing of therapy but was dependent on baseline gas transfer
Source: Annual Congress 2008 - Management of COPD
Year: 2008

Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study
Source: Eur Respir J, 57 (3) 2002823; 10.1183/13993003.02823-2020
Year: 2021



An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020


Single dose budesonide/carmoterol fixed combination improves lung function over 24 hours in patients with moderate to severe persistent asthma
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


The presence of desaturation during ambulation is an important marker of subsequent mortality in patients with ²early UIP²
Source: Eur Respir J 2004; 24: Suppl. 48, 55s
Year: 2004

Minimal clinically important difference for daily pedometer step count in COPD
Source: ERJ Open Res, 7 (1) 00823-2020; 10.1183/23120541.00823-2020
Year: 2021



The influence of different schemes of basic treatment on functional indices in moderate–severe asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 54s
Year: 2006

Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness
Source: Eur Respir J, 56 (2) 1902202; 10.1183/13993003.02202-2019
Year: 2020



Is a positive response to a pulmonary rehailitation programme associated with a longer persistence of the improvement?
Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease
Year: 2009

Are patients who report persistent symptoms and days lost due to asthma more likely to be hospitalised in the subsequent year?
Source: Eur Respir J 2002; 20: Suppl. 38, 204s
Year: 2002

Minimal clinically important difference for measures of fatigue, cough and sputum
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019

Test-retest reliability, minimal detectable change and minimal clinically important differences in the modified shuttle walk test in children and adolescents with cystic fibrosis
Source: Virtual Congress 2020 – Clinical year in review
Year: 2020

Minimal clinically important difference of the Brief-BESTest in COPD
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020


Minimal clinically important difference of the clinical COPD questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 689s
Year: 2004

Differences in symptoms that precede an exacerbation that influence treatment decisions
Source: Annual Congress 2008 - COPD
Year: 2008